Terminated PHASE3 INTERVENTIONAL 2-arm NCT00330135

The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis

Multicentre, Randomized, Placebo-Controlled, Double-Blind Clinical Trial to Investigate the Efficacy of Sodium Hyaluronate in Patients With Symptomatic Hip Osteoarthritis

Sponsor: Daiichi Sankyo

Conditions Symptomatic Hip Osteoarthritis

Interventions Sodium hyaluronate placebo injection

Updated 7 times since 2017 Last updated: Jan 7, 2008 Started: Jan 31, 2005 Primary completion: Mar 31, 2007 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Daiichi Sankyo

See all terminations from Daiichi Sankyo

This PHASE3 trial investigates Symptomatic Hip Osteoarthritis and is currently terminated or withdrawn. Daiichi Sankyo leads this study, which shows 7 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Mar 2024 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Mar 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Sep 2017 [monthly]

Terminated PHASE3

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo

Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rueil-Malmaison, France